Project Grant R01DA063592
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Arkansas, Fayetteville a $418,372 Project Grant effective September 1, 2025, through August 31, 2030, under the Drug Use and Addiction Research Programs (CFDA 93.279). This translational research project evaluates depressive symptomology and smoking cessation treatment mechanisms through just-in-time adaptive interventions (JITAIs). The research addresses a critical gap in smoking...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Miriam Hospital a $1.53 million Project Grant (CFDA 93.279: Drug Use and Addiction Research Programs) effective August 1, 2025, through April 30, 2030, to investigate the effects of endogenous and exogenous ovarian hormones on electronic nicotine delivery systems (ENDS) use among young women. The research addresses a documented public health gap: young women experience disproportionately higher rates of ENDS use,...
- Federal Project Grant Award Summary Oregon Health & Science University received a $905,044 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded May 1, 2026, with completion scheduled for April 30, 2028. The award funds a mixed-methods research study examining current assessment practices and documentation of electronic nicotine delivery systems (ENDS) use in primary care settings across 22 clinics serving...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $431,643 under its Drug Use and Addiction Research Programs (CFDA 93.279) to The Research Foundation for the State University of New York (SUNY at Binghamton) on August 1, 2025, for a two-year project concluding July 31, 2027. This Project Grant funds the development and pilot testing of a telehealth-delivered, pain-targeted motivational smoking intervention designed for smokers with chronic pain who are not ready to...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $144,372 Project Grant to Washington University on May 15, 2026, through the Drug Use and Addiction Research Programs (CFDA 93.279) to support research on the implementation speed and scale-up of personalized tobacco use treatment. The award funds a Mentored Career Development (K02) grant for a recently tenured investigator conducting research that bridges precision medicine and implementation science....
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $200,676 K23 Career Development Grant to the University of Wisconsin–Madison on September 1, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279). This five-year award supports the development of machine learning approaches to advance personalized smoking cessation risk prediction and intervention in adults attempting to quit smoking. The research leverages existing datasets from diverse adult...
- Federal Grant Award Summary Oklahoma State University Center for Health Sciences received a $377,586 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded February 15, 2026, with completion targeted for January 31, 2028. The award funds research examining sex-specific sumoylation mechanisms in heroin-seeking behavior and associated neuroadaptations. The research addresses a critical public health need, as heroin...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $367,362 Project Grant to Henry Ford Health + Michigan State University Health Sciences effective March 15, 2026, through February 28, 2031, under the Drug Use and Addiction Research Programs (CFDA 93.279). The award funds the patient-engaged development and testing of a technology-based intervention designed to reduce prenatal cannabis use. The project will develop an Electronic Screening and Brief...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Medical University of South Carolina a $249,000 Project Grant on June 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate social-contextual stressors affecting smoking cessation and relapse among socioeconomically disadvantaged young adults (SDYA). The research project, scheduled for completion by May 31, 2029, addresses a critical public health gap by examining how...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Boston Children's Hospital a $489,500 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning June 1, 2025 and concluding May 31, 2027. This research initiative develops and validates remote oral fluid testing procedures to assess cannabis non-use as a key outcome measure in clinical trials targeting younger adults aged 18-30 years with cannabis use disorder (CUD). The project...
The National Institute on Drug Abuse (NIDA) awarded Arkansas Children's Research Institute a $675,774 Project Grant effective July 1, 2026, through April 30, 2031, under the Drug Use and Addiction Research Programs (CFDA 93.279). This research initiative identifies hormonal and digital biomarkers predictive of smoking cessation outcomes in women of reproductive age through a fully remote, national natural-experiment study design. The project addresses critical gaps in the clinical literature by expanding research to include women using hormonal contraceptives and those with irregular menstrual cycles, measuring multiple ovarian hormones (progesterone, estradiol, and ethinyl estradiol), and investigating digital biomarkers that correlate with hormonal fluctuations, such as body temperature changes during ovulation. The study aims to develop personalized medicine approaches that improve the efficacy of smoking cessation interventions for women, a population demonstrating lower response rates to evidence-based cessation treatments and greater vulnerability to smoking-related morbidity and mortality compared to men. Data collection will employ four methodological approaches, including urinary ovarian hormone measurement and digital biomarker assessment across a diverse participant sample. The deliverables will generate empirical evidence on the relationship between hormonal fluctuations and smoking behavior, establishing a scientific foundation for tailored cessation interventions informed by individual hormonal profiles and measurable physiological indicators.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $675.8k | 7/1/26 |